ClinVar Miner

Submissions for variant NM_000535.7(PMS2):c.137G>A (p.Ser46Asn) (rs121434629)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000524431 SCV000552059 pathogenic Hereditary nonpolyposis colorectal neoplasms 2019-10-21 criteria provided, single submitter clinical testing This sequence change replaces serine with asparagine at codon 46 of the PMS2 protein (p.Ser46Asn). The serine residue is highly conserved and there is a small physicochemical difference between serine and asparagine. This variant is present in population databases (rs121434629, ExAC 0.003%). This variant has been observed in individuals affected with clinical features of Lynch syndrome (PMID: 26866578, 25006859, Invitae). Also, this variant has been observed on the opposite chromosome (in trans) from a pathogenic variant in an individual affected with constitutional mismatch repair deficiency syndrome (PMID: 18273873). ClinVar contains an entry for this variant (Variation ID: 91301). This variant has been reported to affect PMS2 protein function (PMID: 24027009). This variant disrupts the p.Ser46 amino acid residue in PMS2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 22577899, 23709753). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Department of Pathology and Laboratory Medicine,Sinai Health System RCV000076806 SCV000592922 likely pathogenic Lynch syndrome 2014-12-11 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000584471 SCV000888391 likely pathogenic not provided 2018-07-12 criteria provided, single submitter clinical testing
Color RCV001185073 SCV001351217 likely pathogenic Hereditary cancer-predisposing syndrome 2019-10-24 criteria provided, single submitter clinical testing
Mayo Clinic Genetic Testing Laboratories,Mayo Clinic RCV000584471 SCV000691980 pathogenic not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.